Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Encompass HealthMEX:EHC 75 EV-to-EBIT is 12.55 as of Jul. 30, 2026, which is 9% below its 10-year median of 13.72. GuruFocus rates MEX:EHC with a GF Score™ of 75/100 and a GF Value™ of MXN1,876.97 (Fairly Valued). The stock has 2 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Encompass Health ranks better than 60.08% on this metric.
The historical rank and industry rank for Encompass Health's EV-to-EBIT or its related term are showing as below:
MEX:EHC'
s EV-to-EBIT Range Over the Past 10 Years
Min: 9.84 Med: 13.72 Max: 19.92
Current: 13.13
During the past 13 years, the highest EV-to-EBIT of Encompass Health was 19.92. The lowest was 9.84. And the median was 13.72.
MEX:EHC's EV-to-EBIT is ranked better than 60.08% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.74
vs MEX:EHC: 13.13
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Encompass Health's Enterprise Value for the quarter that ended in Mar. 2026 was MXN190,814 Mil.
Encompass Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN20,593 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Encompass Health EV-to-EBIT Related Terms
Encompass Health EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Encompass Health's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Encompass Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Encompass Health EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Encompass Health's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Encompass Health's EV-to-EBIT falls into.
Encompass Health's current Enterprise Value is MXN258,368 Mil.
Encompass Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN20,593 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Encompass Health (MEX:EHC) has a EV-to-EBIT of 12.55 as of Jul. 30, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Encompass Health and its competitors. This is near median its historical median of 13.72. Over the past decade, Encompass Health's EV-to-EBIT has ranged from 9.84 to 19.92. According to the industry distribution chart, Encompass Health ranks #188 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 39.9%.
Is Encompass Health's EV-to-EBIT too high?
Encompass Health's current EV-to-EBIT of 12.55 is near median its 10-year median of 13.72. Over the past 10 years, this metric has ranged from a low of 9.84 to a high of 19.92. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Encompass Health's value of 12.55 is 20.3% below this industry median. Based on the distribution chart, Encompass Health ranks #188 out of 471 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Encompass Health has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Encompass Health's EV-to-EBIT compare to ENSG and UHS?
According to the Healthcare Providers & Services industry distribution chart, Encompass Health ranks #188 out of 471 companies for EV-to-EBIT. This puts Encompass Health in the upper half of its industry. The industry median EV-to-EBIT is 15.74. Encompass Health's value of 12.55 is 20.3% below this benchmark. Historically, Encompass Health's own EV-to-EBIT has ranged from 9.84 to 19.92 over the past decade. While the company's 10-year median is 13.72 vs. the industry median of 15.74, Encompass Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Encompass Health's current EV-to-EBIT of 12.55 is 20.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Encompass Health and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Encompass Health's current EV-to-EBIT is 12.55, which is near median its own 10-year median of 13.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Encompass Health stock overvalued right now?
Based on GuruFocus' analysis, Encompass Health (MEX:EHC) is currently considered Fairly Valued. The stock's GF Value™ is MXN1,876.97, compared to a current price of MXN1,935.00 — trading 3.1% above its estimated fair value. The current EV-to-EBIT is 12.55, which is near median its 10-year median of 13.72 and 20.3% below the Healthcare Providers & Services industry median of 15.74. Encompass Health's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Encompass Health (MEX:EHC), the current EV-to-EBIT is 12.55 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Encompass Health (MEX:EHC) Overvalued in 2026?
Based on GuruFocus' analysis, Encompass Health stock appears to be overvalued.
The current stock price of MXN1,935.00 is trading 3.1% above its estimated GF Value™ of MXN1,876.97.
GuruFocus considers Encompass Health to be Fairly Valued.
Key valuation signals for MEX:EHC:
EV-to-EBIT: 12.55 (near median its 10-year median of 13.72)
GF Value™: MXN1,876.97 vs. price of MXN1,935.00 (3.1% above fair value)
Industry Position: 20.3% below the Healthcare Providers & Services median (#188 of 471)
No single metric tells the full story. See the MEX:EHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
75GF Score
Get the complete analysis for MEX:EHC
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:EHC has been successfully added to your 
